Trial
NCT02899156
Flumazenil for Hypoactive Delirium Secondary to Benzodiazepine Exposure
Phase IVTERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
University of California, Davis
Collaborators
—
Condition
Hypoactive Delirium
Intervention
Flumazenil
Why stopped
A planned interim analysis led to the trial being stopped early based on the observed size effect and power analysis.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-07-23